National University Corporation Hokkaido University
发明人:
申请号：
EP18855070.1
公开号：
EP3683311A1
申请日:
2018.09.10
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention provides: a peptide that includes a partial amino acid sequence of the C16orf74 protein, includes the cysteine at position 7 and/or the cysteine at position 14 of the C16orf74 protein, and inhibits dimer formation of the C16orf74 protein； a pharmaceutical composition for cancer treatment that includes the peptide； and a screening method for cancer treatment drugs that takes as the indicator inhibition of dimer formation of the C16orf74 protein.
